All Relations between Alzheimer Disease and microtubule-associated protein tau

Publication Sentence Publish Date Extraction Date Species
Jeremy Koppel, Chris Acker, Peter Davies, Oscar L Lopez, Heidy Jimenez, Miriam Azose, Blaine S Greenwald, Patrick S Murray, Caitlin M Kirkwood, Julia Kofler, Robert A Swee. Psychotic Alzheimer's disease is associated with gender-specific tau phosphorylation abnormalities. Neurobiology of aging. vol 35. issue 9. 2015-02-12. PMID:24731519. converging evidence suggests that psychotic alzheimer's disease (ad + p) is associated with an acceleration of frontal degeneration, with tau pathology playing a primary role. 2015-02-12 2023-08-13 human
Cyril Laurent, Sabiha Eddarkaoui, Maxime Derisbourg, Antoine Leboucher, Dominique Demeyer, Sébastien Carrier, Marion Schneider, Malika Hamdane, Christa E Müller, Luc Buée, David Blu. Beneficial effects of caffeine in a transgenic model of Alzheimer's disease-like tau pathology. Neurobiology of aging. vol 35. issue 9. 2015-02-12. PMID:24780254. beneficial effects of caffeine in a transgenic model of alzheimer's disease-like tau pathology. 2015-02-12 2023-08-13 mouse
Cyril Laurent, Sabiha Eddarkaoui, Maxime Derisbourg, Antoine Leboucher, Dominique Demeyer, Sébastien Carrier, Marion Schneider, Malika Hamdane, Christa E Müller, Luc Buée, David Blu. Beneficial effects of caffeine in a transgenic model of Alzheimer's disease-like tau pathology. Neurobiology of aging. vol 35. issue 9. 2015-02-12. PMID:24780254. tau pathology found in alzheimer's disease (ad) is crucial in cognitive decline. 2015-02-12 2023-08-13 mouse
Victor L Villemagne, Shozo Furumoto, Michelle T Fodero-Tavoletti, Rachel S Mulligan, John Hodges, Ryuichi Harada, Paul Yates, Olivier Piguet, Svetlana Pejoska, Vincent Doré, Kazuhiko Yanai, Colin L Masters, Yukitsuka Kudo, Christopher C Rowe, Nobuyuki Okamur. In vivo evaluation of a novel tau imaging tracer for Alzheimer's disease. European journal of nuclear medicine and molecular imaging. vol 41. issue 5. 2015-02-09. PMID:24514874. in vivo evaluation of a novel tau imaging tracer for alzheimer's disease. 2015-02-09 2023-08-12 human
Sreeram Krishnan, P Ran. Evaluation of selenium, redox status and their association with plasma amyloid/tau in Alzheimer's disease. Biological trace element research. vol 158. issue 2. 2015-02-09. PMID:24682919. the aim of the study was to evaluate blood selenium and antioxidants as possible oxidative stress markers in alzheimer's disease (ad) along with amyloid β42 (aβ42) and tau by comparing them with vascular dementia (vd) and age-matched healthy controls. 2015-02-09 2023-08-12 Not clear
Jun Wang, Merina Varghese, Kenjiro Ono, Masahito Yamada, Samara Levine, Nikos Tzavaras, Bing Gong, William J Hurst, Robert D Blitzer, Giulio Maria Pasinett. Cocoa extracts reduce oligomerization of amyloid-β: implications for cognitive improvement in Alzheimer's disease. Journal of Alzheimer's disease : JAD. vol 41. issue 2. 2015-02-09. PMID:24957018. alzheimer's disease (ad) is the most common age-related neurodegenerative disorder, characterized by pathological aggregates of amyloid peptide-β (aβ) and tau protein. 2015-02-09 2023-08-13 Not clear
Xiu-Ping Liu, Xiang Qian, Yue Xie, Yan Qi, Min-Feng Peng, Bi-Cui Zhan, Zheng-Qing Lo. Betaine suppressed Aβ generation by altering amyloid precursor protein processing. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. vol 35. issue 7. 2015-02-07. PMID:24549986. recent findings shown that betaine rescued neuronal damage due to homocysteine induced alzheimer's disease (ad) like pathological cascade, including tau hyperphosphorylation and amyloid-β (aβ) deposition. 2015-02-07 2023-08-12 human
Xianhong Zheng, Weiwei Wang, Ruizhi Liu, Honglan Huang, Rihui Zhang, Liankun Su. Effect of p62 on tau hyperphosphorylation in a rat model of Alzheimer's disease. Neural regeneration research. vol 7. issue 17. 2015-02-06. PMID:25657660. effect of p62 on tau hyperphosphorylation in a rat model of alzheimer's disease. 2015-02-06 2023-08-13 rat
Xianhong Zheng, Weiwei Wang, Ruizhi Liu, Honglan Huang, Rihui Zhang, Liankun Su. Effect of p62 on tau hyperphosphorylation in a rat model of Alzheimer's disease. Neural regeneration research. vol 7. issue 17. 2015-02-06. PMID:25657660. tau hyperphosphorylation is a main cause of neuronal loss in alzheimer's disease, which can be caused by many factors, including oxidative stress. 2015-02-06 2023-08-13 rat
Xianhong Zheng, Weiwei Wang, Ruizhi Liu, Honglan Huang, Rihui Zhang, Liankun Su. Effect of p62 on tau hyperphosphorylation in a rat model of Alzheimer's disease. Neural regeneration research. vol 7. issue 17. 2015-02-06. PMID:25657660. moreover, the anti-oxidative capability of the nf-e2-related factor 2-antioxidant response element pathway was decreased, which may be the cause of tau hyperphosphorylation in alzheimer's disease brain tissue and the subsequent structural and functional damage to neurons. 2015-02-06 2023-08-13 rat
Guoli Song, Zhonghao Zhang, Lei Wen, Chen Chen, Qingxue Shi, Yu Zhang, Jiazuan Ni, Qiong Li. Selenomethionine ameliorates cognitive decline, reduces tau hyperphosphorylation, and reverses synaptic deficit in the triple transgenic mouse model of Alzheimer's disease. Journal of Alzheimer's disease : JAD. vol 41. issue 1. 2015-01-29. PMID:24577479. selenomethionine ameliorates cognitive decline, reduces tau hyperphosphorylation, and reverses synaptic deficit in the triple transgenic mouse model of alzheimer's disease. 2015-01-29 2023-08-12 mouse
Markus Mandler, Lauren Walker, Radmila Santic, Peter Hanson, Ajeet Rijal Upadhaya, Sean J Colloby, Christopher M Morris, Dietmar R Thal, Alan J Thomas, Achim Schneeberger, Johannes Attem. Pyroglutamylated amyloid-β is associated with hyperphosphorylated tau and severity of Alzheimer's disease. Acta neuropathologica. vol 128. issue 1. 2015-01-28. PMID:24861310. pyroglutamylated amyloid-β is associated with hyperphosphorylated tau and severity of alzheimer's disease. 2015-01-28 2023-08-13 human
E Giraldo, A Lloret, T Fuchsberger, J Viñ. Aβ and tau toxicities in Alzheimer's are linked via oxidative stress-induced p38 activation: protective role of vitamin E. Redox biology. vol 2. 2015-01-28. PMID:25061569. aβ and tau toxicities in alzheimer's are linked via oxidative stress-induced p38 activation: protective role of vitamin e. oxidative stress is a hallmark of alzheimer's disease (ad). 2015-01-28 2023-08-13 mouse
Whitney Fornicola, Ari Pelcovits, Bei-Xu Li, Jonathan Heath, George Perry, Rudy J Castellan. Alzheimer Disease Pathology in Middle Age Reveals a Spatial-Temporal Disconnect Between Amyloid-β and Phosphorylated Tau. The open neurology journal. vol 8. 2015-01-28. PMID:25628768. alzheimer disease pathology in middle age reveals a spatial-temporal disconnect between amyloid-β and phosphorylated tau. 2015-01-28 2023-08-13 Not clear
Matthew Faull, Simon Yl Ching, Anna I Jarmolowicz, John Beilby, Peter K Panegyre. Comparison of two methods for the analysis of CSF Aβ and tau in the diagnosis of Alzheimer's disease. American journal of neurodegenerative disease. vol 3. issue 3. 2015-01-28. PMID:25628965. comparison of two methods for the analysis of csf aβ and tau in the diagnosis of alzheimer's disease. 2015-01-28 2023-08-13 Not clear
E Coppi, L Ferrari, R Santangelo, F Caso, P Pinto, G Passerini, G Comi, G Magnan. Further evidence about the crucial role of CSF biomarkers in diagnosis of posterior cortical atrophy. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. vol 35. issue 5. 2015-01-27. PMID:24487699. cerebrospinal fluid (csf) biomarkers (protein tau, phosphorylated tau and amyloid beta 1-42) are recognized as a supportive feature in diagnosis of alzheimer's disease (ad) and their role in identifying atypical variants of ad is currently under investigation. 2015-01-27 2023-08-12 Not clear
Ping Zheng, Sandy R Shultz, Chris M Hovens, Dennis Velakoulis, Nigel C Jones, Terence J O'Brie. Hyperphosphorylated tau is implicated in acquired epilepsy and neuropsychiatric comorbidities. Molecular neurobiology. vol 49. issue 3. 2015-01-26. PMID:24323428. recent studies have implicated the hyperphosphorylated tubulin-associated protein (tau) in rodent models of epilepsy and alzheimer's disease, and in experimental and clinical studies of traumatic brain injury. 2015-01-26 2023-08-12 Not clear
Christina R Muratore, Heather C Rice, Priya Srikanth, Dana G Callahan, Taehwan Shin, Lawrence N P Benjamin, Dominic M Walsh, Dennis J Selkoe, Tracy L Young-Pears. The familial Alzheimer's disease APPV717I mutation alters APP processing and Tau expression in iPSC-derived neurons. Human molecular genetics. vol 23. issue 13. 2015-01-26. PMID:24524897. the familial alzheimer's disease appv717i mutation alters app processing and tau expression in ipsc-derived neurons. 2015-01-26 2023-08-12 human
Christina R Muratore, Heather C Rice, Priya Srikanth, Dana G Callahan, Taehwan Shin, Lawrence N P Benjamin, Dominic M Walsh, Dennis J Selkoe, Tracy L Young-Pears. The familial Alzheimer's disease APPV717I mutation alters APP processing and Tau expression in iPSC-derived neurons. Human molecular genetics. vol 23. issue 13. 2015-01-26. PMID:24524897. alzheimer's disease (ad) is a complex neurodegenerative disorder characterized by extracellular plaques containing amyloid β (aβ)-protein and intracellular tangles containing hyperphosphorylated tau protein. 2015-01-26 2023-08-12 human
Eva Borger, Abigail Herrmann, David A Mann, Tara Spires-Jones, Frank Gunn-Moor. The calcium-binding protein EFhd2 modulates synapse formation in vitro and is linked to human dementia. Journal of neuropathology and experimental neurology. vol 73. issue 12. 2015-01-26. PMID:25383639. efhd2 is a calcium-binding adaptor protein that has been found to be associated with pathologically aggregated tau in the brain in alzheimer disease and in a mouse model of frontotemporal dementia. 2015-01-26 2023-08-13 mouse